Skip to main content
. 2017 Feb 24;8(19):31509–31520. doi: 10.18632/oncotarget.15663

Figure 2. Recurrence-free survival (RFS) and overall survival (OS) curves, and the association between AURKA expression and survival.

Figure 2

RFS curve (A) and OS curve (B), respectively, and the 5-year RFS and OS were 23.26% and 27.91%, respectively. (C-D) Kaplan-Meier plots of (C) RFS and (D) OS in 129 patients with CSCC according to AURKA expression. The P values for survival comparison, which were obtained by log-rank test, were all less than 0.05.